| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL
PT RO SE SI SK TR |
|
Designated Extension States: |
|
AL BA MK RS |
| (30) |
Priority: |
24.12.2007 US 16524 P
27.05.2008 US 56206 P
|
| (43) |
Date of publication of application: |
|
01.09.2010 Bulletin 2010/35 |
| (60) |
Divisional application: |
|
16180926.4 |
| (73) |
Proprietors: |
|
- ID Biomedical Corporation of Quebec
Quebec G1P 4R8 (CA)
- GlaxoSmithKline Biologicals S.A.
1330 Rixensart (BE)
|
|
| (72) |
Inventors: |
|
- BAUDOUX, Jean-Pierre
B-1330 Rixensart (BE)
- BLAIS, Normand
Laval
Québec H6V 3S8 (CA)
- RHEAULT, Patrick
Laval
Québec H7V 3S8 (CA)
- RUELLE, Jean-Louis
B-1330 Rixensart (BE)
|
| (74) |
Representative: Thornley, Rachel Mary et al |
|
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB) |
| (56) |
References cited: :
WO-A2-2008/114149
|
WO-A2-2008/154456
|
|
| |
|
|
- YIN HSIEN-SHENG ET AL: "Structure of the parainfluenza virus 5 F protein in its metastable,
prefusion conformation", NATURE: INTERNATIONAL WEEKLY JOURNAL OF SCIENCE, NATURE PUBLISHING
GROUP, UNITED KINGDOM, vol. 439, no. 7072, 1 January 2006 (2006-01-01), pages 38-44,
XP002503490, ISSN: 0028-0836, DOI: 10.1038/NATURE04322
- BEGONA RUIZ-ARGUELLO M ET AL: "Effect of Proteolytic Processing at Two Distinct Sites
on Shape and Aggregation of an Anchorless Fusion Protein of Human Respiratory Syncytial
Virus and Fate of the Intervening Segment", VIROLOGY, ACADEMIC PRESS,ORLANDO, US,
vol. 298, no. 2, 5 July 2002 (2002-07-05), pages 317-326, XP004469494, ISSN: 0042-6822,
DOI: 10.1006/VIRO.2002.1497
- VAN DRUNEN LITTEL-VAN DEN HURK S ET AL: "Immunopathology of RSV infection: prospects
for developing vaccines without this complication", REVIEWS IN MEDICAL VIROLOGY, CHICHESTER,
GB, vol. 17, no. 1, 1 January 2007 (2007-01-01), pages 5-34, XP002510797, ISSN: 1052-9276,
DOI: 10.1002/RMV.518 [retrieved on 2006-09-27]
- PRINCE GREGORY A ET AL: "Efficacy and safety studies of a recombinant chimeric respiratory
syncytial virus FG glycoprotein vaccine in cotton rats", JOURNAL OF VIROLOGY, THE
AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 74, no. 22, 1 November 2000 (2000-11-01),
pages 10287-10292, XP002676837, ISSN: 0022-538X
- SINGH ET AL: "Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse
model", VACCINE, ELSEVIER LTD, GB, vol. 25, no. 33, 24 July 2007 (2007-07-24) , pages
6211-6223, XP022168621, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2007.05.068
- TERNETTE ET AL: "Immunogenicity and efficacy of codon optimized DNA vaccines encoding
the F-protein of respiratory syncytial virus", VACCINE, ELSEVIER LTD, GB, vol. 25,
no. 41, 27 September 2007 (2007-09-27), pages 7271-7279, XP022276681, ISSN: 0264-410X,
DOI: 10.1016/J.VACCINE.2007.07.025
- CALDER L J ET AL: "Electron Microscopy of the Human Respiratory Syncytial Virus Fusion
Protein and Complexes That It Forms with Monoclonal Antibodies", VIROLOGY, ACADEMIC
PRESS,ORLANDO, US, vol. 271, no. 1, 25 May 2000 (2000-05-25), pages 122-131, XP004436029,
ISSN: 0042-6822, DOI: 10.1006/VIRO.2000.0279
- ULBRANDT NANCY D ET AL: "Identification of antibody neutralization epitopes on the
fusion protein of human metapneumovirus", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR
GENERAL MICROBIOLOGY, SPENCERS WOOD, GB, vol. 89, no. Part 12, 1 December 2008 (2008-12-01),
pages 3113-3118, XP002604581, ISSN: 0022-1317, DOI: 10.1099/VIR.0.2008/005199-0
- MARTIN, D. ET AL.: 'Sequence elements of the fusion peptide of human respiratory syncytial
viru fusion protein required for activity.' JOURNAL OF GENERAL VIROLOGY vol. 87, no.
6, June 2006, pages 1649 - 1658, XP002600413
- GONZALEZ-REYES, L. ET AL.: 'Cleavage of the human respiratory syncytial virus fusion
protein at two distinct sites is required for activation of membrane fusion.' PROCEEDINGS
OF THE NATIONAL ACADEMY OF SCIENCE USA vol. 98, no. 17, 14 August 2001, pages 9859
- 9864, XP008136810
- YIN, H.-S. ET AL.: 'Structure of the parainfluenza virus 5 F protein in its metastable,
prefusion conformation.' NATURE vol. 439, no. 7072, 05 January 2006, pages 38 - 44,
XP002600415
- SCHMIDT, A. C. ET AL.: 'Mucosal immunization of rhesus monkeys against respiratory
syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a
live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus
type 3 vector backbone.' JOURNAL OF VIROLOGY vol. 76, no. 3, February 2002, pages
1089 - 1099, XP002978183
- HUANG Y. ET AL.: 'Modulation of protective immunity, eosinophilia, and cytokine responses
by selective mutagenesis of a recombinant G protein vaccine against respiratory syncytial
virus.' JOURNAL OF VIROLOGY vol. 79, no. 7, April 2005, pages 4527 - 4532, XP002600416
- TANG, R. S. ET AL.: 'Parainfluenza virus type 3 expressing the native or soluble fusion
(F) protein of respiratory syncytial virus (RSV) confers protection from RSV infection
in African green monkeys.' JOURNAL OF VIROLOGY vol. 78, no. 20, October 2004, pages
11198 - 11207, XP002600417
- VALARCHER, J.-F. ET AL.: 'Bovine respiratory syncytial virus lacking the virokinin
or with a mutation in furin cleavage site RA(R/K)R109 induces less pulmonary inflammation
without impeding the induction of protective immunity in calves.' JOURNAL OF GENERAL
VIROLOGY vol. 87, no. 6, June 2006, pages 1659 - 1667, XP008136764
|
|
